(2S)-1-[2-[tert-butyl(dimethyl)silyl]-1,3-dithian-2-yl]-3-(2-propan-2-yl-1,3-dithian-2-yl)propan-2-ol
C20H40OS4Si — CID 101388822
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-1-[2-[tert-butyl(dimethyl)silyl]-1,3-dithian-2-yl]-3-(2-propan-2-yl-1,3-dithian-2-yl)propan-2-ol
(2S)-1-[2-[tert-butyl(dimethyl)silyl]-1,3-dithian-2-yl]-3-(2-propan-2-yl-1,3-dithian-2-yl)propan-2-ol (PubChem CID 101388822) has the molecular formula C20H40OS4Si and a molecular weight of 452.89 g/mol. Its IUPAC name is (2S)-1-[2-[tert-butyl(dimethyl)silyl]-1,3-dithian-2-yl]-3-(2-propan-2-yl-1,3-dithian-2-yl)propan-2-ol.
Molecular Properties
| Compound Name | (2S)-1-[2-[tert-butyl(dimethyl)silyl]-1,3-dithian-2-yl]-3-(2-propan-2-yl-1,3-dithian-2-yl)propan-2-ol |
|---|---|
| PubChem CID | 101388822 |
| Molecular Formula | C20H40OS4Si |
| Molecular Weight | 452.89 g/mol |
| Exact Mass | 452.17 |
| IUPAC Name | (2S)-1-[2-[tert-butyl(dimethyl)silyl]-1,3-dithian-2-yl]-3-(2-propan-2-yl-1,3-dithian-2-yl)propan-2-ol |
| SMILES | CC(C)C1(C[C@H](O)CC2([Si](C)(C)C(C)(C)C)SCCCS2)SCCCS1 |
| InChI | InChI=1S/C20H40OS4Si/c1-16(2)19(22-10-8-11-23-19)14-17(21)15-20(24-12-9-13-25-20)26(6,7)18(3,4)5/h16-17,21H,8-15H2,1-7H3/t17-/m0/s1 |
| InChIKey | FUNKJFBYEDCVOP-KRWDZBQOSA-N |
| XLogP | 6.96 |
| TPSA | 20.23 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.89 |
| LogP ≤ 5 | 6.96 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 101388822 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.